INTRODUCTION
The precise subcellular localization of components of cell signalling networks which allows the spatio-temporal control of signalling is of major importance in biology [1, 2] . This is exemplified by signalling systems employing the cyclic nucleotides cAMP and cGMP. The local concentrations of cyclic nucleotides is controlled by the precise positioning within the cell of the cyclases that catalyse their formation [3, 4] , and of cyclic nucleotide PDEs (phosphodiesterases) that catalyse their degradation [5, 6] . Indeed, it has been shown recently that PDEs can be tethered to subcellular targets by exquisitely precise interactions [7, 8] . The result is tight control of cyclic-nucleotide-regulated effector molecules such as cAMP-or cGMP-dependent protein kinases [8] [9] [10] . The subcellular localization of PDEs therefore has fundamental consequences for cellular physiology.
Many of the proteins involved in signal-transduction events undergo some form of post-translational lipid modification essential for their correct localization and function, including N-terminal myristoylation and C-terminal isoprenylation and palmitoylation [11, 12] . Proteins are traditionally thought to undergo isoprenylation at a consensus C-terminal CaaX-box motif, where C is a cysteine residue, a is an aliphatic residue and X is any residue [13] . However, recent analysis suggests that certain non-aliphatic residues can exist at position + 1 after the conserved cysteine residue, and that there is a clear preference for hydrophobic residues at position + 3 [14] . Isoprenylation is thought to be an important mediator of protein-membrane interactions. For example, ablation of prenylation in the H-, N-and K-Ras GTPase family completely redistributes these membranebound proteins to the cytosol [15] . PDE6 (phosphodiesterase type 6, the mammalian retinal cGMP-specific phosphodiesterase) has been shown to undergo C-terminal isoprenylation at its α, β and α catalytic subunits [16] [17] [18] . The PDE6 α and α subunits are modified by farnesyl lipids, whereas the β subunit is modified by the addition of geranylgeranyl groups. Such modifications are apparently required for binding of these PDEs to rod-outer-segment membranes [18] . Several prenylated proteins, including retinal PDE6 catalytic subunits, GRK1 [G-proteincoupled-receptor kinase 1 (rhodopsin kinase)] and the small GTPases Ha-Ras and Rap have been shown to bind to the PrBP/δ (prenyl-binding protein, formerly PDEδ) [19] [20] [21] . PrBP/δ participates in the transport of PDE6 catalytic subunits and GRK1 from the endoplasmic reticulum, where prenylation occurs, to photoreceptor outer segments [22] .
In the genetic model organism Drosophila melanogaster, a close sequence and functional homologue of both vertebrate PDE5 [23] and PDE6 [24] , DmPDE5/6 (Drosophila melanogaster PDE5/6), has been identified [25] . DmPDE5/6 is a high-K m enzyme that specifically hydrolyses cGMP and is sensitive to the PDE5-selective inhibitors sildenafil and zaprinast [26, 27] . DmPDE5/6 also contains a C-terminal CaaX-box prenylation Abbreviations used: cGMP-PDE, cGMP-specific phosphodiesterase; DAPI, 4 ,6 -diamidino-2-phenylindole; DmPDE, Drosophila melanogaster phosphodiesterase; DmPrBP, Drosophila melanogaster prenyl-binding protein; DTT, dithiothreitol; EGFP, enhanced green fluorescent protein; FT, farnesyl transferase; GFP, green fluorescent protein; GGT1, geranylgeranyl transferase 1; GGTI-286, GGT inhibitor 286; GRK1, G-protein-coupled-receptor kinase 1 (rhodopsin kinase); MVA, mevalonic acid; PDE5, phosphodiesterase type 5; PDE6, phosphodiesterase type 6; Sf9, Spodoptera frugiperda (fall armyworm) 9; suPDE5, sea-urchin (S. purpuratus) PDE5; UAS, upstream activation sequence. 1 To whom correspondence should be addressed (email m.houslay@bio.gla.ac.uk).
motif [25] . In Drosophila, endogenous DmPDE5/6 expression has been documented in head and body [25] , as well as in the Malpighian (renal) tubule [28] , a cGMP-modulated transporting epithelium that is critical for detoxification, osmoregulation and immunity. Recent work has demonstrated a novel role in the modulation of cGMP efflux by DmPDE5/6 in this tubule [28] . Drosophila transgenics [29] allow a sophisticated system for ectopic overexpression or ablation of genes of choice in particular cell types or tissues in the intact animal. Thus the tubule provides a powerful in vivo model in which to assess regulation and function of novel cGMP-PDEs. We show that DmPDE5/6 is a prenylated enzyme that is a member of a family of PDE5-like enzymes with prenylation motifs. We also show that DmPDE5/6 can associate with DmPrBP/δ and show that the localization of DmPDE5/6 in the tubule is altered when its prenylation is ablated.
MATERIALS AND METHODS

Bioinformatics
The amino acid sequences of DmPDE5/6 (encoded by gene CG8279) homologues were identified by BLAST-searching the non-redundant peptide sequence database using DmPDE5/6 as the query sequence. Retrieved sequences were individually examined for the presence of putative CaaX-box prenylation motifs. Those sequences containing such motifs were subjected to further analysis using the PrePS (prenylation prediction suite; http:// mendel.imp.ac.at/sat/PrePS/index.html) [14] . Accession numbers of sequences were as follows: D. pseudoobscura (fruitfly), GA20950-XP_001358768; Anopheles gambiae (African malaria mosquito), AGAP004119-XP_312997; Apis mellifera (honeybee), XP_394107; Triboleum castaneum (rust-red flour beetle), XP_967847; Strongylocentrotus pupuratus (purple sea-urchin), PDE5a-NP_001029121; Danio rerio (zebrafish), XP_697567; Xenopus tropicalis (West African clawed frog), PDE5a-NP_001072812; Homo sapiens (man), PDE6A-P16499; H. sapiens, PDE6B-NP_000274; H. sapiens, PDE6C-P51160; H. sapiens, PDE5A1-NP_001074.2; H. sapiens, PDE11A4-NP_058649.3; D. melanogaster (fruitfly) Ras85D-NP_476699. Alignment of the C-terminal 25 amino acids of selected proteins and sequence similarity trees were made using ClustalW (http:// www.ebi.ac.uk/clustalw/) and drawn using BioEdit (http://www. mbio.ncsu.edu/ BioEdit/bioedit.html).
DmPrBP/δ (encoded by gene CG9296) was identified from Flybase (http://flybase.bio.indiana.edu/.bin/fbidq.html? FBgn0032059).
Site-directed mutagenesis of PDE6
Targeted PCR mutagenesis of DmPDE5/6 Cys 1128 to serine (to achieve DmPDE5/6-C1128S) was performed according to a commercial mutagenesis protocol (Stratagene). The DmPDE5/6 (CG8279) plasmid template was PCR-amplified using primers (details available on request from M.D.H.) designed to achieve the TGC-to-AGC mutation and to include complementary flanking sequences of 20 bp. Purified PCR products were digested with DpnI to remove template DNA, and 2 μl of the digest was used to transform chemically competent DH5α cells.
Expression of DmPDE5/6 in Sf9 [Spodoptera frugiperda (fall armyworm) 9] insect cells
Recombinant baculovirus generation utilized the BaculoGold system (BD PharMingen). The open reading frames encoding wild-type DmPDE5/6 and DmPDE5-6 C1128S, tagged at the N-terminus with the V5 epitope sequence GKPIPNPLLGLDST, were cloned into the baculovirus transfer vector pVL1393 (BD PharMingen) using the BamHI and NotI restriction sites, and the plasmids were purified. For all infections, a P2 recombinant viral stock, generated after two rounds of amplification via standard methods, was used. For protein expression, 5 × 10 6 Sf 9 cells at exponential growth were plated into 75 cm 2 cell-culture flasks in 9 ml of Sf-900 II serum-free medium (Invitrogen). A 0.5 ml portion of P2 viral stock was added and cells were incubated at 27
• C for 36 h. Cells were harvested by centrifugation at 2000 g for 5 min, the supernatant discarded and the cell pellet was used either for labelling experiments or for PDE assays.
In vitro prenylation experiments
Three aliquots of 5 × 10 6 Sf 9 cells were plated into 75 cm 2 cellculture flasks in 10 ml of medium and allowed to adhere for 30 min before addition of 0.5 ml of recombinant viral stock.
Infection was allowed to proceed for 24 h before addition of mevinolin (lovastatin; Sigma) (40 μmol/l) for 1 h, after which cells were centrifuged for 2 min at 1000 g and resuspended in 2 ml of medium. Cells were then incubated for 16 h in 25 μCi · ml −1 H]mevalonic acid (39 Ci/mmol; Sigma) and then harvested, washed once in PBS, and pelleted by centrifugation at 1500 g for 2 min. The pellet was lysed in 200 μl of 3T3 lysis buffer [25 mM Hepes, pH 7.4, 50 mM NaCl, 10 % (v/v) glycerol and 1 % Triton X-100] and the protein concentration measured. A 70 μg portion of protein was removed for Western-blot analysis and DmPDE5/6 was immunoprecipitated from the remaining protein sample with purified polyclonal anti-DmPDE5/6 antibody using standard procedures [25] . The Protein A-Sepharose beads were boiled in 10 μl of SDS loading buffer and used to load two SDS/10%-(w/v)-PAGE gels. One gel was run for Western-blot analysis and loaded with 10 μg of total protein, or 3 μl of immunoprecipitated protein sample, per lane; and the other was used for fluorography and loaded with 60 μg of total protein and the remainder (20 μl) of the precipitated protein per lane. The gel for fluorography was treated with Enlight (Mo Bi Tec) for 1 h, dried, then fluorographed at − 70
• C for 1-4 weeks. The gel for Western blotting was processed as described below.
Cloning and expression of DmPDE5/6, DmPDE5/6 C1128S, DmRas85D and DmPrBP/δ in Drosophila S2 cells
In order to generate V5-epitope-tagged proteins, DmPDE5/6, cloned as described in [25] , and DmPrBP/δ, were cloned into the S2 vector pMT/V5-HIS-TOPO (Invitrogen). For cloning of Drosophila Ras85D, the Ras85D gene was amplified from an expressed sequence tag (RE53955) obtained from the BDGP (Berkeley Drosophila Genome Project; http://www.fruitfly.org/ EST/index.shtml) using forward primer (incorporating a BglII restriction site) and reverse primer (incorporating a NotI restriction site). In order to generate GFP (green fluorescent protein)-tagged Ras85D, the coding sequence for EGFP (enhanced GFP) was PCR-amplified [forward primer incorporating a BamHI restriction site and optimal Kozak sequence (ACCATGG); reverse primer incorporating a BamHI restriction site], digested, then cloned at the 5 end of Ras85D using the BglII restriction site. The resulting construct was cloned into pMT/V5-HIS-TOPO vector. The open reading frame of DmPrBP/δ was PCR-amplified from genomic DNA template using a reverse primer omitting the stop codon, and directly cloned into pMT/V5-HIS-TOPO (Invitrogen). For co-localization of DmPDE5/6 with DmPrBP/δ a pMT/GFP:DmPDE5/6 vector was generated by inserting the EGFP coding sequence at the 5 end of the DmPDE5/6 open reading frame. These plasmids were then used for the transient transfection of S2 cells under conditions of Cu 2+ -inducible expression. Cells were cultured according to standard protocols [30] . Approx. 3 × 10 6 cells were used in each transfection, performed using Cellfectin ® (Invitrogen); transfection efficiencies were routinely 10-25 %.
Fractionation experiments
Cellular fractionation was carried out on approx. 3 × 10 6 transiently transfected S2 cells. After harvesting and washing, cells were lysed by incubation on ice for 10 min in 80 μl of ice-cold hypo-osmotic buffer [10 mM Tris/HCl, pH 7.5, 5 mM MgCl 2 , 1 mM DTT (dithiothreitol) and a 1:100 dilution of protease-inhibitor cocktail (Sigma)] and then passed through a finegauge needle ten times. The homogenate was then adjusted to 0.2 M sucrose by the addition of 0.1 vol. of 2 M sucrose solution and subjected to 10 min centrifugation at 1000 g at 4
• C. The pellet was retained as the P1 fraction, and supernatant removed to a fresh tube and centrifuged for 10 min at 15 000 g at 4
• C. The resulting pellet was retained as the P15 fraction, and supernatant removed to a fresh tube and centrifuged for 30 min at 100 000 g at 4
• C to yield the P100 fraction. The supernatant was retained as the S100 fraction. Pellets were washed once in sucrose buffer and resuspended in 88 μl of detergent buffer [50 mM Tris/HCl and 2 % (v/v) Igepal ® (= Nonidet 40; Sigma), pH 7.5], and 20 μl each of supernatant and resuspended pellets were analysed by Western blotting. For separation into S15 and P15 fractions ( Figure 3 below) cells were lysed as above in a volume of 100 ml and lysates adjusted to 0.2 mol/l sucrose. Lysates were centrifuged at 15 000 g for 5 min at 4 o C, and supernatants were removed to fresh tubes. Pellets were washed once in hypo-osmotic buffer before resuspension in 100 ml of detergent buffer. Equal volumes of supernatant and resuspended pellet were then analysed by Western blotting.
Western blotting
Tubule or cell samples were homogenized on ice in 3T3 lysis buffer with protease-inhibitor cocktail (Sigma). Typically, 20 μg of protein samples were separated by SDS/10%-(w/v)-PAGE. Western blotting was carried out using the ECL ® Western blotting analysis system (Amersham Pharmacia) according to standard protocols using either a 1:5000 dilution of anti-(V5 epitope) antibody (Invitrogen), followed by a 1:5000 dilution of anti-mouse secondary antibody (Amersham Biosciences) [31] , or using a monoclonal anti-GFP antibody (Zymed) at 1:1000 dilution.
Immunocytochemistry and confocal microscopy
Immunocytochemistry of S2 cells was carried out according to standard protocols [31] using cells immobilized on poly-L-lysinecoated coverslips. Samples were processed and treated with a 1:1000 dilution of anti-(V5 epitope) primary antibody (Invitrogen), with secondary staining using FITC-conjugated (1:500; Jackson ImmunoResearch Laboratories) or Texas Red-conjugated (1:500; AbCam) anti-mouse antibodies. Cell nuclei were stained with DAPI (4 ,6 -diamidino-2-phenylindole) hydrochloride at 1 μg/ml. The coverslips to which samples were attached were then mounted on slides using Vectashield mounting medium (Vector Laboratories) and sealed with glycerol/gelatin.
Tubules expressing GFP-DmPDE5/6 or GFP-C1128S-DmPDE5/6 in principal cells were dissected in Schneider's medium and mounted on poly-L-lysine-coated slides. Tubules were fixed and permeabilized as previously described [32] and incubated for 1 h in 1 mg/ml Texas Red-conjugated phalloidin (Sigma) -an F-actin stain indicative of tubule apical membrane [33] -in PBS/0.3 % Triton. After washing, tubules were DAPIstained as described above. Slides were mounted in Vectashield. Samples were imaged using a Zeiss 510 Meta confocal micrscope coupled with an inverted Zeiss microscope using a 405 nm diode laser/420-480 nm band-pass filter for DAPI, an HeNe1 543 nm laser/561-754 nm band-pass filter for Texas Red and an argon 488 nm laser/505-50 nm band-pass filter for FITC.
Generation of transgenic lines
The sequence for C1128S-DmPDE5/6 was subcloned into pPmt vector [34] and used to transform Drosophila embryos according to standard techniques as previously described [35] . This allows chromosomal insertion of a UAS-GFP-C1128S-DmPDE5/6 transgene in transformed embryos (UAS is upstream activation sequence).
Drosophila stocks
All strains were maintained on standard Drosophila diet at 25
• C and 55 % humidity, on a 12 h light:12 h dark photoperiod. Drosophila lines used in the present study were: w 1118 (parental strain used for transformation of embryos); UAS-GFP:DmPDE5/6 (allows targeted expression of GFP-tagged DmPDE5/6 [28] ); UAS-GFP:C1128S-DmPDE5/6 (transgenic lines generated for the present study; allows targeted expression of GFP-tagged C1128S-DmPDE5/6); and c42 (transcription factor GAL4 enhancer trap line used to drive expression of UAS constructs in only tubule principal cells [35, 36] ). The following lines were also used, which were the progeny of crosses between c42 and specific UAS transgenic lines: c42/UAS-GFP:DmPDE5/6 and c42/UAS-GFP:C1128S-DmPDE5/6. Adults were used at 7 days post-emergence for all experiments.
cGMP-PDE assays
Assays for cGMP-PDE in tubules were performed as previously described [25, 37] [25] . K m and relative V max values for DmPDE5/6 and C1128S-DmPDE5/6 expressed in Sf 9 cells were determined by carrying out Western-blot analysis of lysates and adjusting the amount of protein used so that equal amounts of DmPDE5/6 was added to each cGMP-PDE reaction. cGMP-PDE assays were carried out on these samples at 1, 2, 5, 10, 20, 50 and 100 μM cGMP final substrate concentration. Final PDE activity was expressed as pmol (or nmol) of cGMP hydrolysed/min per mg of protein.
cGMP transport assays
Transport assays were based on the methodology used to study ouabain transport [38] and performed according to previously published protocols [28] . Malpighian tubules from 7-day-old adult fruitflies were set up as for a standard fluid transport assay, as previously described [25] . Experiments were carried out at 100 μM cGMP in the presence of 0. cGMP-PDE sequences containing putative CaaX-box prenylation motifs were identified using BLAST searching of the non-redundant protein database with DmPDE5/6 as the query sequence. Protein sequences were aligned and sequence similarity tree was generated using ClustalW (http://www.ebi.ac.uk/Tools/clustalw/) [46] . (A) Alignment of the C-terminal 25 amino acids of CaaX-box cGMP-PDEs (sequence information highlighted in grey) and DmRas85D, showing conserved CaaX-box cysteine residue, shaded black. (B) Sequence similarity tree of cGMP-PDEs with CaaX-box prenylation motifs (highlighted in grey) with human PDE5A1, human PDE11A4 and human retinal PDE catalytic subunits as reference sequences.
1 h, and the diameters of the secreted droplets were measured. Secreted droplets, and a 1 μl aliquot of each bathing droplet, were then removed to Eppendorf tubes containing lquid-scintillation fluid. The rate of cGMP transport, in fmol/min, was calculated by using the following equation:
where S is the radioactivity (c.p.m.) in the secreted drop, [cGMP] is the cGMP concentration in μM, B is the radioactivity (c.p.m.) in the bathing drop and t is the time in min. The transport ratio was calculated by dividing the concentration of [ 3 H]cGMP in the secreted droplet by the concentration of [ 3 H]cGMP in the bathing droplet. These experiments were performed on tubules from UAS-GFP:C1128S-DmPDE5/6 and c42/UAS-GFP:C1128S-DmPDE5/6 lines. Data for DmPDE5/6 transgenic tubules have been published [28] . Results are expressed as either mean rate of transport (pmol of cGMP/min) or the mean transport ratio + − S.E.M. (n = 12).
Statistics
Where appropriate, statistical significance was assessed using Student's t-test for unpaired samples, taking P < 0.05 as the critical value.
RESULTS
DmPDE5/6 is prenylated at a C-terminal CaaX box
The intracellular targeting of PDEs underpins the generation of intracellular gradients, pools and sinks for cyclic nucleotides, thus providing a critical factor in the regulation of cyclicnucleotide signalling [8, 9] . In a number of systems, prenylation has been shown to provide an important means of regulating the intracellular distribution of signalling molecules by conferring membrane association [12] . To date, however, the catalytic subunits of mammalian PDE6, which are found exclusively in the visual system [39] , provide the only PDE for which prenylation has been demonstrated. However, the C-terminus of DmPDE5/6 contains a CaaX-box motif of a form such that might be predicted to be modified by the addition of an isoprenyl lipid ( Figure 1A and [25] ).
We also investigated the possibility that other non-retinal cGMP-PDEs might have CaaX-box prenylation motifs. Database searches were performed using DmPDE5/6 as a query sequence. The results from this bioinformatics analysis revealed the presence of several further putative cGMP-PDEs that contain possible CaaX-box motifs ( Figure 1A) . Alignment of these novel sequences with mammalian PDEs showed that they are more closely related to mammalian PDE5 or PDE11 than the retinal PDE catalytic subunits ( Figure 1B and Table 1 ). We noted that six out of seven of the putative CaaX boxes contained non-consensus sequences, particularly at the + 1 and + 3 positions with respect to the conserved cysteine residue ( Figure 1A ). To investigate whether these sequences could be functional CaaX boxes, each putative PDE was submitted for analysis by the PrePS. This analysis suggested that DmPDE5/6, D. pseudoobscura GA20950, A. gambiae AGAP004119 and T. castaneum XP_967847 are likely substrates for GGT1 (geranylgeranyl transferase 1), whereas A. mellifera XP_394107 and S. purpuratus PDE5a [40] are likely substrates for FT (farnesyl transferase) ( Table 1 ). The novel putative vertebrate cGMP-PDEs, D. rerio XP_697567 and X. tropicalis PDE5a, were not predicted to undergo prenylation using this algorithm (Table 1) . In order to gain insight into the importance of the CaaX box for the prenylation of DmPDE5/6, the putative prenylated Cys 1128 was mutated to a conservative serine residue (C1128S). Radiolabelling experiments allowed us to demonstrate posttranslational isoprenylation of DmPDE5/6 in vivo. Incubation of cells with 3 [H]MVA ([ 3 H]mevalonic acid), the precursor of isoprenyl pyrophosphate, has been shown to specifically label prenylated proteins [41] . To increase the sensitivity of labelling, the synthesis of isoprenyl groups from endogenous mevaldate was inhibited by the addition of mevinolin (also known as lovastatin), a 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor, prior to the addition of [ 3 H]MVA [41] . The Sf 9 cell expression system has previously been shown to result in high levels of correctly modified retinal PDE6 subunits [18] and was used here to produce sufficient V5-epitope-tagged DmPDE5/6 and C1128S-DmPDE5/6 protein for labelling experiments (Figure 2A) .
Western-blot analysis of cell lysates prepared from DmPDE5/6 or C1128S-DmPDE5/6-infected Sf 9 cells (pretreated with mevinolin and labelled with [ 3 H]MVA) with anti-(V5 epitope) antibody shows that DmPDE5/6 and C1128S-DmPDE5/6 constructs are expressed at the anticipated size, namely 130 kDa (Figure 2A, lanes 1 and 2) . Immunoprecipitation of cell lysates with anti-DmPDE5/6 antibody [25] increases the amount of DmPDE5/6 and C1128S-DmPDE5/6 proteins ( Figure 2A , lanes 4 and 5). Control (uninfected) cell lysates show no immunoreactive species on the Western blot (Figure 2A, lanes 3 and 6) . Corresponding results from SDS/PAGE and autofluorograph analysis ( Figure 2B Figure 2C ). However, DmPDE5/6 was found to have a relative V max for cGMP hydrolysis approx. 2.2-fold greater than that of C1128S-DmPDE5/6 ( Figure 2C ).
Disruption of prenylation alters the subcellular distribution of DmPDE5/6 and Ras85D in S2 cells
In order to investigate potential alterations in the subcellular localization of DmPDE5/6 upon ablation of prenylation, V5-epitopetagged DmPDE5/6 and C1128S-DmPDE5/6 constructs were transfected into Drosophila S2 cells. Wild-type DmPDE5/6 is localized to the plasma membrane ( Figure 3A ). In contrast with this, C1128S-DmPDE5/6 is distributed throughout the cytoplasm ( Figure 3B ). In order to determine whether the altered distribution was due to removal of prenylation rather than simply mutation of Cys 1128 per se, we treated S2 cells expressing wild-type DmPDE5/6 with GGTI-286 (GGT inhibitor 286) (1 μM) [42] . This resulted in redistribution of DmPDE5/6 throughout the cytoplasm ( Figure 3C ), indicating that prenylation is required for plasma-membrane targeting in S2 cells.
The subcellular localization of DmPDE5/6 and C1128S-DmPDE5/6 was also assessed by subcellular fractionation. Lysed S2 cells were separated into cytosolic and particulate fractions using centrifugation, followed by detection of DmPDE5/6 by Western blotting. DmPDE5/6 was found predominantly in the particulate P15 fraction ( Figure 3A, lower panel) . By contrast, prenyl-deficient C1128S-DmPDE5/6 was found predominantly in the soluble S15 fraction ( Figure 3B , lower panel). Consistent with confocal immunohistochemical analyses, treatment of transfected S2 cells with GGTI-286 resulted in wild-type DmPDE5/6 being predominantly localized in the S15 fraction ( Figure 3C , lower panel). Two bands corresponding to DmPDE5/6 are present in the soluble fraction in Figures 3(B) and 3(C) . The lower-apparentmolecular-mass species may represent proteolytic fragments of non-prenylated DmPDE5/6. Alternatively, the different bands may correspond to distinct phosphorylation states of the enzyme.
To confirm that the Drosophila S2 cell line is a useful system with which to analyse the subcellular localization of prenylated proteins, we expressed GFP-tagged Drosophila Ras85D, a protein known to undergo lipid modification [43, 44] . Indeed, in all mammalian Ras isoforms, mutation of the putative prenylated cysteine residue to serine has been shown to prevent the attachment of the isoprenyl group. Drosophila Ras85D encodes a C-terminal CaaX-box ending in a leucine residue, with a proximal polybasic region ( Figure 1A ), suggesting that Drosophila Ras is a canonical prenylated protein. Confocal analysis shows that GFP-tagged Drosophila Ras localizes to the plasma membrane with staining of intracellular vesicles and fainter staining of the perinuclear region when expressed in Drosophila S2 cells ( Figure 3D ). Furthermore, treatment of GFP-Ras85D-expressing cells with 1 μM GGTI-286 resulted in redistribution of GFPRas85D throughout the cytoplasm ( Figure 3E ). These data provide strong evidence that Ras85D undergoes prenylation in S2 cells and that pharmacological inhibition of this process alters its subcellular localization. Furthermore, this suggests that Drosophila S2 cells constitute a useful model for studies of prenylated proteins.
Fractionation experiments confirmed the redistribution of Ras85D in S2 cells after GGTI-286 treatment. GFP-Ras85D is evenly distributed between the insoluble and soluble fractions ( Figure 3D, lower panel) . However, pretreatment of S2 cells with GGTI-286 completely relocalizes Ras85D to the soluble S15 fraction ( Figure 3E, lower panel) .
DmPrBP/δ modulates localization of DmPDE5/6 in Drosophila
Given that retinal PDE6 interacts with PrBP/δ and that DmPDE5/6 does undergo prenylation in vivo, we investigated the existence of a PrBP/δ homologue in Drosophila and the possibility that DmPDE5/6 might interact with DmPrBP/δ. DmPrBP/δ is a polypeptide of 151 amino acids, encoded by gene CG9296 (http:// flybase.bio.indiana.edu/reports/FBgn0032059.html). Alignment with mammalian prenyl-binding proteins shows that the CG9296 gene product is highly similar to both human and mouse PrBP/δ, with 61 % identity and 78 % similarity, over the entire polypeptide sequence, to human PrBP/δ [20] . When expressed in S2 cells, DmPrBP/δ is targeted predominantly to the nucleus, with less intense staining in the cytoplasm ( Figure 4A ). Fractionation followed by Western blotting showed that DmPrBP/δ is predominantly soluble ( Figure 4A, lower panel) . To determine whether DmPDE5/6 and DmPrBP/δ interact in vivo, GFP-tagged DmPDE5/6 and V5-epitope-tagged DmPrBP/δ were transfected into S2 cells and their subcellular localization was ascertained by confocal microscopy. Strikingly, when DmPDE5/6 is co-transfected with DmPrBP/δ, the localization of DmPDE5/6 is altered from the plasma membrane to a predominantly intracellular location (compare Figure 3A with Figure 4B , panel i). Indeed, in co-transfection studies the subcellular location of DmPDE5/6 now coincides with that of DmPrBP/δ ( Figure 4B , panel iii), suggesting that DmPDE5/6 has been sequestered to DmPrBP/δ. Although, these data suggest that DmPrBP/δ provides the dominant intracellular localization signal, it seems that DmPDE5/6 is not without effect on the localization of DmPrBP/δ. Thus, in this regard, the nuclear localization of DmPrBP/δ appears to be compromised when it is co-expressed with DmPDE5/6 compared with when it is expressed alone (contrast Figure 4B , panel ii, with Figure 4A ).
In order to confirm that DmPDE5/6 and DmPrBP/δ can exist in the same complex, co-immunoprecipitation was performed. DmPDE5/6 and DmPrBP/δ were co-transfected into S2 cells and DmPDE5/6 was immunoprecipitated with a polyclonal DmPDE5/6 antibody [25] . Western blotting of the immunoprecipitates confirmed that DmPrBP/δ interacts with DmPDE5/6 ( Figure 4C ).
To confirm further that interaction with DmPrBP/δ altered DmPDE5/6 intracellular localization, subcellular fractionation was undertaken. S2 cells were transfected with either V5-tagged DmPDE5/6 or V5-tagged DmPrBP/δ alone or co-transfected with both proteins, lysed and then separated using differential centrifugation ( Figure 5A ). The collected fractions were then analysed by Western blotting. When expressed alone, DmPDE5/6 was found predominantly in the particulate P1 fraction (Figure 5B) , whereas DmPrBP/δ expressed alone resided mainly in the soluble S100 fraction ( Figure 5C ). In contrast with this, when Plasmids encoding wild-type DmPDE5/6 (A), C1128S mutation of DmPDE5/6 (B) and GFP-tagged Ras85D (D) were expressed in S2 cells. DmPDE5/6 and C1128S-DmPDE5/6 were localized with anti-V5 antibody using confocal microscopy. (C and E) Transfected cells were also treated with the prenylation inhibitor GGTI-286, transfected with DmPDE5/6 (C) and GFP-tagged Ras85D (E) and the expressed protein was visualized accordingly. Control (untransfected) cells did not show staining with anti-V5 antibody (results not shown). In all panels, single cells are shown in which cell nuclei were stained with DAPI (blue). Scale bars in all images correspond to 5 μm. (A-E, lower panels) Cell fractionation and Western blotting of DmPDE5/6 and C1128S-DmPDE5/6 using anti-V5 antibody (130 kDa) and of GFP:Ras85D (50 kDa) using anti-GFP antibody. Fractions assayed for presence of expressed protein were P15 and S15 as described in the Materials and methods section.
co-expressed with DmPrBP/δ, DmPDE5/6 occurred mainly in the microsomal P100 fraction ( Figure 4D ; 130 kDa species). Consistent with the confocal immunohistochemical studies, DmPrBP/δ showed a change in localization when co-expressed with DmPDE5/6, becoming evenly distributed between the P1, P100 and S100 fractions ( Figure 5D ; 22 kDa species).
Localization of C1128S-DmPDE5/6 is disrupted in vivo
In order to gain insight into the role of prenylated DmPDE5/ 6 in vivo, the Drosophila Malpighian (renal) tubules were utilized as an organotypic screen for DmPDE5/6 function. Previous work had demonstrated that DmPDE5/6 is endogenously expressed in tubules [28] . Furthermore, generation of transgenic fruitflies expressing N-terminal GFP-tagged DmPDE5/6 showed that DmPDE5/6 is localized to the apical membrane of principal cells in tubules [28] .
In the present study a UAS transgenic line was generated (GFP:C1128S-DmPDE5/6) that allowed targeted expression of GFP-tagged prenylation-deficient C1128S-DmPDE5/6 in specific cell types via GAL4 enhancer-trap drivers. Specific expression of GFP-tagged C1128S-DmPDE5/6 in tubule principal cells is effectively achieved using the c42 GAL4 driver [35, 36] . In c42/ GFP:C1128S-DmPDE5/6 tubules, staining is mostly observed in the cytoplasm ( Figure 6A ) compared with GFP:DmPDE5/6 staining, which is located in the apical membrane ( Figure 6B and [28] ), as indicated by co-localization with the apical membrane marker F-actin [33] . However, it is also apparent that a fraction of C1128S-DmPDE5/6 is able to associate with the apical membrane ( Figure 6A ). This is supported by fractionation studies (Figure 3) , where ablation of prenylation via the C1128S mutation does not completely remove DmPDE5/6 from the membrane to the cytosolic fraction of S2 cells. These data indicate that, although prenylation provides a major membrane targeting signal, there are undoubtedly additional independent signals that are involved in driving the specific localization of DmPDE5/6 to the apical membrane.
C1128S-DmPDE5/6 retains biological activity
Tubules expressing C1128S-DmPDE5/6 in the principal cells have significantly increased cGMP-PDE activity compared with (C) Co-immunoprecipitation of DmPDE5/6 with DmPrBP/δ. S2 cells were transiently transfected with DmPDE5/6 and DmPrBP/δ, or with DmPrBP/δ on its own. Cell lysates were subjected to Western blotting to confirm expression of constructs (bottom two panels) and DmPDE5/6 was immunoprecipitated using an anti-DmPDE5/6 polyclonal antibody. Western analysis confirmed that DmPDE6 was precipitated (second panel), whereas the top panel shows that DmPrBP/δ co-precipitated with DmPDE5/6. control tubules, showing that the transgene is an active cGMP-PDE in vivo ( Figure 6C ). cGMP-PDE activity is significantly reduced compared with that observed with the transgene encoding wild-type GFP-tagged DmPDE5/6. This may be due to lower expression levels ( Figure 6D ) and/or the lower V max of C1128S-DmPDE5/6 ( Figure 2C ) compared with wild-type. Previous work had shown that DmPDE5/6 directly modulates transport of cGMP (efflux) by the tubule [28] : targeted overexpression of DmPDE5/6 inhibits rates of cGMP efflux, whereas targeted knock-down via RNA interference significantly increases cGMP efflux. Expression of C1128S-DmPDE5/6 in principal cells also inhibits cGMP transport rate and ratio ( Figures 6E and 6F ) and to the same extent as that induced by DmPDE5/6 overexpression ( Figures 6G and 6H) .
DISCUSSION
The precise targeting of PDEs to specific subcellular locations provides a mechanism for the spatio-temporal control of cyclicnucleotide-mediated signalling events [6, 45, 46] . Prenylation is a lipid post-translational modification that works synergistically with a second signal to promote the membrane association and, consequently, the biological activity, of many proteins [47] . For example, prenylation of the small GTPase Ras is essential for both its membrane-binding and transforming activity [43] . In the mammalian retina, prenylation of the catalytic PDE subunits is required for their binding to the rod-outer-segment membrane and, by inference, effective control of cGMP-mediated visual signal transduction [17] . We show here that DmPDE5/6 undergoes isoprenyl post-translational modification at its C-terminal CaaXbox motif. This is the first non-retinal PDE for which such modification has been demonstrated.
In addition to DmPDE5/6, we have identified a number of putative non-retinal cGMP-PDEs that contain CaaX-box motifs and are predicted to undergo prenylation, suggesting that prenylation may be a conserved feature important for their function. Of these, functional data is only available for suPDE5 [sea-urchin (S. purpuratus) PDE5], a cGMP-PDE involved in sperm motility that is regulated by phosphorylation and pH changes [40] . The presence of a CaaX-box motif within suPDE5 suggests that prenylation may represent another form of regulation for this enzyme. It will be of interest to determine whether suPDE5 is indeed prenylated in vivo.
Two putative CaaX-box-containing PDE sequences, X. tropicalis PDE5a and D. rerio XP_697567, have C-terminal regions divergent from that of DmPDE5/6. Analysis by the PrePS software suggested that neither X. tropicalis PDE5a nor D. rerio XP_697567 undergoes prenylation in vivo, owing to the presence of unfavourable residues in the + 1 to + 3 positions after the conserved cysteine residue. However, we also noted, using the same software, that D. melanogaster Ras85D was predicted not to be a substrate for either GGT1 or FT, although our data clearly demonstrate a change in localization of Ras upon treatment of cells with GGTI-286 ( Figures 3D and 3E ). This may reflect the relative paucity of published data regarding prenylated Drosophila proteins that is available for database compilation, suggesting that there is scope for prenylation in vivo of even unfavourable substrates.
Site-directed mutagenesis of the conserved CaaX-box cysteine (C1128S) in DmPDE5/6 ablates prenylation and modifies localization of DmPDE5/6 to the cytoplasm in S2 cells. However, subcellular fractionation of S2 cells reveals that a significant proportion of C1128S-DmPDE5/6 remains in the insoluble fraction. In addition to this, C1128S-DmPDE5/6 still shows partial association with the apical membrane when expressed in tubule principal cells. Therefore, removal of DmPDE5/6 prenylation is not sufficient to disrupt completely its localization. This suggests that although prenylation forms an important part of the localization machinery for DmPDE5/6, additional motifs are required for the fidelity of DmPDE5/6 targeting. Indeed, in many proteins multiple signals are required for efficient targeting to membranes and to signalling complexes [7, 15, 48, 49] This may involve multiple lipid modifications or multiple sites of protein interaction. For example, K-Ras requires both farnesylation and a polybasic region for efficient membrane targeting [15] . However, unlike DmPDE5/6, removal of K-Ras prenylation renders this protein completely soluble [15] , suggesting that the targeting sequences for DmPDE5/6 are more complex than for K-Ras. Interestingly, both positive and negative plasma-membrane targeting sequences have been found within the palmitoylated GRK6A [48] . It is plausible that additional sequences facilitating plasma-membrane localization operate within DmPDE5/6.
The fractionation experiments ( Figure 3 ) reveal that two bands corresponding to prenylation-inhibited wild-type DmPDE5/6 and C1128S-DmPDE5/6 are present in the cytosolic fractions. The lower-apparent-molecular-mass species may represent proteolytic fragments of non-prenylated DmPDE5/6, suggesting that nonprenylated DmPDE5/6 may be more prone to degradation than is the wild-type enzyme. Alternatively, the different bands may correspond to distinct phosphorylation states of the DmPDE5/6. This raises the intriguing possibility that prenylation may either protect DmPDE5/6 from phosphorylation by preventing access of a cytosolic kinase or promote phosphorylation by localizing DmPDE5/6 to a site where an active kinase resides. Further work will be required to distinguish between these possibilities.
Although we could not identify the species of prenyl group that modifies DmPDE5/6, we consider it likely that DmPDE5/6 is modified with a geranylgeranyl group for two reasons. First, the C-terminal amino acid of the DmPDE5/6 CaaX-box is leucine, which normally serves as substrate for GGT1 [50] . Secondly, we have used the GGT-specific inhibitor GGTI-286 in our experiments, which is highly specific for GGT1, and is 15 times more potent at inhibiting GGT1 compared with FT in vivo [42] . With GGTI-286 we show that the subcellular localization of both Ras85D and DmPDE5/6 is altered upon inhibition of prenyltransferase activity. Drosophila possesses homologues of each mammalian prenyltransferase gene [11] . It is therefore likely that the specificity of prenyltransferase inhibitor action will be conserved between mammal and the fruitfly. Furthermore, work investigating the prenylation of Drosophila Ras, which also has a leucine at its C-terminus, suggests that this protein undergoes modification with a geranylgeranyl group [44] .
Mammalian PrBP/δ binds to the prenylated C-terminus of the retinal PDE6 catalytic subunits [51] , probably serving to sequester the lipid group from the surrounding solvent [52] . We show here that DmPDE5/6 interacts with DmPrBP/δ when these proteins are expressed in S2 cells (Figure 4) . This is the first demonstration The transgenic UAS-GFP:C1128S-DmPDE5/6 line was generated and crossed to the principal-cell-specific c42 driver. Tubules from adult progeny were dissected, stained for the apical membrane marker F-actin using phalloidin and counterstained with the nuclear stain DAPI. (A) c42/GFP:C1128S-DmPDE5/6. (B) For comparison, staining in c42/GFP:DmPDE5/6 transgenic tubules [17] is shown. Scale bars represent 10 μm; the tubule diameter can be taken to be 35 μm. In (A) and (B), green fluorescence denotes GFP-tagged C1128S-DmPDE5/6 (A: apical staining indicated by white arrows; cytoplasmic staining indicated by yellow arrow) or GFP-tagged DmPDE5/6 (B: apical staining indicated by white arrows, basolateral staining indicated by blue arrow); F-actin is stained red, and nuclei are stained blue. No GFP signal was observed in either parental c42 or UAS tubules (results not shown). (C) The C1128S-DmPDE5/6 transgene encodes active cGMP-PDE enzyme in tubules. Measurements of cGMP-PDE activity in tubules from c42, UAS-GFP:C1128S-DmPDE5/6 and c42/UAS-GFP:DmPDE5/6 C1128S are shown. For clarity, data for cGMP-PDE activity in tubules of UAS-GFP:DmPDE5/6 and c42/UAS-GFP:DmPDE5/6 [17] are included. Data are expressed as mean cGMP-PDE activity (pmol of cGMP/min per mg of protein, means + − S.E.M., n = 3-6). Significance (compared with parental lines) is denoted by *P < 0.05 (Student's t test). (D) Western blot of GFP:C1128S-DmPDE5/6 and GFP:DmPDE5/6 expressed in principal cells using anti-GFP antibody (top panel); loading control using anti-γ -tubulin antibody (lower panel). (E) Rates of cGMP transport for UAS-GFP:C1128S-DmPDE5/6 and c42/UAS-GFP:C1128S-DmPDE5/6 tubules are shown. (F) cGMP transport ratio, where active transport is defined as a ratio of more than 1, in UAS-GFP:C1128S-DmPDE5/6 and c42/UAS-GFP:C1128S-DmPDE5/6 tubules. (G) Rates of cGMP transport for UAS-GFP:DmPDE5/6 and c42/UAS-GFP:DmPDE5/6 tubules. (H) cGMP transport ratios for UAS-GFP:DmPDE5/6 and c42/UAS-GFP:DmPDE5/6 tubules. cGMP transport rate data are expressed as pmol of cGMP/min (means + − S.E.M., n = 12. The transport ratios are expressed as means + − S.E.M., n = 12. Significance is denoted by *P < 0.05 (Student's t test).
of association of a non-retinal PDE with PrBP/δ. Indeed, co-expression of DmPrBP/δ redirects a large proportion of DmPDE5/6 from the plasma membrane to an intracellular location. These data are consistent with the formation of complexes of DmPrBP/δ and DmPDE5/6 where intracellular targeting signals may be compromised in a number of ways. They could be masked, either with the geranylgeranyl group on DmPDE5/6 being bound to DmPrBP/δ or through steric hindrance through protein-protein interaction, which may ablate, compromise or reprogramme interactions. Furthermore, if targeting signals remain on each protein, then sequestering proteins will serve to compete for the DmPDE5/6-DmPrBP/δ complex, their efficacy being driven by their concentration and relative affinity. The Malpighian tubule of Drosophila transports cGMP from the basolateral haemolymph to the lumen [28] . Overexpression of DmPDE5/6 in the tubule principal cell has been shown to inhibit cGMP transport. Despite the altered subcellular localization of C1128S-DmPDE5/6, overexpression of non-prenylated DmPDE5/6 in principal cells also inhibits cGMP transport. This is likely due to the mass of overexpressed C1128S-DmPDE5/6 in the tubule, enabling a biological response in spite of the altered subcellular localization. Alternatively, residual targeting of C1128S-DmPDE5/6 to the apical membrane may account for the inhibition of cGMP transport in these tubules.
The identification here of the first non-retinal cGMP-PDE to undergo prenylation, and the detection of several cGMP-PDEs with CaaX-boxes, suggests that prenylation of PDEs may be more common than previously thought. The molecular characterization of further putative prenylated cGMP-PDEs will help to shed light on the importance of prenylation for cGMP-mediated signal transduction in non-retinal tissue. Further investigation of DmPDE5/6 function may provide insights into the role of prenylated nonretinal PDEs from other species.
